Updates to the NCCN guidelines recommend HEPZATO KIT for use in hepatic-dominant uveal melanoma as a Category 2A treatment option.
2025
Can a simple blood test spot the signs of skin cancer returning?
A BURY-BORN mum diagnosed with skin cancer after a chance encounter is helping researchers to trial a pioneering blood test that can spot signs of melanoma returning.
Lifileucel Approval Paves the Way for Personalized Minimally-Invasive T-Cell Therapies
The FDA’s accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.
New cancer vaccine method boosts potency and scope
Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for melanoma.